Reference
- Foon, K.A. and Fisher, RI. (1995) Lymphomas. In Williams Hematology, edited by E. Beutler, M.A. Lichtman, B.S. Coller, T.J. Kipps. Pp 1076–1096. New York: McGraw-Hill, Inc.
- Coiffier, B. (2001) Non-Hodgkin's lymphoma: Clinical presentation and outcome. Pp 31. Basel: F. Hoffmann-La Roche Ltd.
- Hiddeman, W., Unterhalt, M., Buske, C. and Sack, H. (1997) "Treatment of follicular lymphomas : current status and future perspectives". J. Intern. Med., 40(Suppl), 55–62.
- Hagenbeek, A., Carde, P., Meerwaldt, J.H., et al. (1998) "Main-tenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma". J. Clin. Oncol., 16, 41 — 47.
- Hainsworth, J.D., Litchy, S., Burris, III H.A., et al. (2002) "Rituximab as first-line and maintenance therapy for patients with indolent non-Hodgkin's lymphoma". J. Clin. Oncol., 20, 4261–4267.
- Manoharan, A. (2002) "Long-term remissions with weekly chlor-ambucil therapy in patients with intermediate-risk chronic lympho-cytic leukaemia". Br. J. Haematol., 118, 1193–1194.
- Sawitsky, A., Rai, KR., Glidewell, 0. and Silver, R.T. (1977) "Comparison of daily versus intermittent chlorambucil and pre-dnisone therapy in the treatment of patients with chronic lymphocytic leukemia". Blood, 50, 1049 — 1059.